Fennec Pharmaceuticals

Yahoo Finance • last year

Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, N.C., June 12, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 24, 2023 (the “Circ... Full story

Yahoo Finance • 3 years ago

DEADLINE ALERT for ASTR, FENC, and GWGH: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, April 11, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the... Full story

Yahoo Finance • 3 years ago

Fennec Pharmaceuticals, Inc. Investors: Reach out to the Portnoy Law Firm prior to the April 11, 2022 Deadline

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, April 08, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NASDAQ: FENC... Full story

Yahoo Finance • 3 years ago

DEADLINE ALERT for TLS, ASTR, FENC, AFIB: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., April 07, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story

Yahoo Finance • 3 years ago

FENC FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important Monday Deadline in Securities Class Action – FENC

NEW YORK, April 07, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between May 28, 2021 and November 26, 2021, inclusiv... Full story

Yahoo Finance • 3 years ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fennec, Astra, Acutus, and Pulse and Encourages Investors to Contact the Firm

NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fennec Pharmaceuticals,... Full story

Yahoo Finance • 3 years ago

全球頂尖投資者法律顧問 ROSEN 鼓勵 Fennec Pharmaceuticals Inc. 投資者在 4 月 11 日證券集體訴訟的重要截止日期前尋求法律意見 – FENC

紐約, April 03, 2022 (GLOBE NEWSWIRE) --  為何：全球投資者權益律師事務所 Rosen Law Firm 提醒在 2021 年 5 月 28 日至 2021 年 11 月 26 日（包括首尾兩天）期間（「集體訴訟期間」）購買了 Fennec Pharmaceuticals Inc. (NASDAQ: FENC) 證券的購買者注意，2022 年 4 月 11 日是首席原告人截止日期的重要日子。 何事：如果您在集體訴訟期間購買了 Fen... Full story

Yahoo Finance • 3 years ago

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 11 Deadline in Securities Class Action – FENC

NEW YORK, April 02, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between May 28, 2021 and November 26, 2021, inclusive... Full story

Yahoo Finance • 3 years ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Telos, Fennec, Astra, and Acutus and Encourages Investors to Contact the Firm

NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Telos Corporation (NASDA... Full story

Yahoo Finance • 3 years ago

(FENC) NEWS: Did you Suffer a Substantial Loss? Contact Johnson Fistel About Leading Fennec Class Action Lawsuit

SAN DIEGO, April 01, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NASDAQ:... Full story

Yahoo Finance • 3 years ago

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fennec Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline – FENC

NEW YORK, March 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NASDAQ: FENC) and certain of its officers. The class action,... Full story

Yahoo Finance • 3 years ago

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fennec Pharmaceuticals Inc. (FENC)

LOS ANGELES, March 30, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 11, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased... Full story

Yahoo Finance • 3 years ago

DEADLINE ALERT for FENC, AFIB, SPWR, and PLSE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, March 28, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the... Full story

Yahoo Finance • 3 years ago

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important April 11 Deadline in Securities Class Action – FENC

NEW YORK, March 28, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between May 28, 2021 and November 26, 2021, inclusiv... Full story

Yahoo Finance • 3 years ago

Fennec Pharmaceuticals to Participate in the 2022 Maxim Virtual Growth Conference

RESEARCH TRIANGLE PARK, N.C., March 25, 2022 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK™ (a unique formulation of sodium thiosulfate)... Full story